CRKL promotes lung cancer cell invasion through ERK‐MMP9 pathway
Authors:
- 24 March 2014
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 54 (S1) , E35-E44
Abstract
CRKL is recently defined as a new oncogene, which plays a role in the lung cancer progression. However, the potential mechanism of CRKL in human non‐small cell lung cancer cell invasion is obscure. We investigated the potential mechanism of CRKL in lung cancer cell invasion using immunohistochemistry, plasmid transfection, Western blotting, real‐time PCR, matrigel invasion assay, chromatin immunoprecipitation assay, and luciferase reporter assay. CRKL expression is higher in lymph node metastatic tumor compared with primary tumor. CRKL overexpression enhanced cell invasion and MMP9 expression in both HBE and H1299 cell lines. There was a significant correlation between CRKL overexpression and high MMP9 expression in primary tumors. MMP‐9 antibody treatment significantly blocked cell invasion. CRKL overexpression also activated AP‐1 luciferase reporter activity, ERK phosphorylation and association of c‐fos to MMP9 promoter. Treatment with ERK inhibitor PD98059 in cells with CRKL transfection inhibited ERK activity, cell invasion, and MMP9 expression. These results suggested that overexpression of CRKL promoted cell invasion through upregulation of MMP9 expression and activation of ERK pathway.Keywords
This publication has 27 references indexed in Scilit:
- Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non–Small Cell Lung CancersCancer Discovery, 2011
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancerOncogene, 2009
- Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activationOncogene, 2005
- Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the populationNature Genetics, 2003
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- CrkL Is Recruited through Its SH2 Domain to the Erythropoietin Receptor and Plays a Role in Lyn-mediated Receptor SignalingJournal of Biological Chemistry, 2001
- Cytokine receptor signallingNature, 1995